Research on Laparoscopic Islet Transplantation for Type 1 Diabetes

Background on Type 1 Diabetes Mellitus

Type 1 diabetes mellitus is a condition marked by elevated glucose levels due to the autoimmune destruction of insulin-producing β cells in the pancreas. Managing this disorder typically requires lifelong insulin therapy and regular blood glucose monitoring. Standard insulin preparations are usually administered through subcutaneous injections, while surgical options like islet transplantation offer an alternative for maintaining blood glucose levels.

Study Overview

A recent study, led by Dr. David Baidal and published in The New England Journal of Medicine, monitored a 43-year-old woman with type 1 diabetes who underwent laparoscopic islet transplantation. The procedure involved transplanting islets onto the omentum, accompanied by immunosuppressive therapy using mycophenolate sodium and tacrolimus to prevent transplant rejection. After eight months, tacrolimus was switched to sirolimus due to the patient experiencing hair loss. Additionally, the patient was advised to engage in regular exercise and follow a low-carbohydrate diet post-transplant.

Monitoring and Results

The research team carefully monitored the patient’s capillary blood glucose levels, glycated hemoglobin, and β cell function scores (BETA and BETA-2, with higher scores indicating better function). Follow-up assessments at 75 days, 6 months, and 12 months post-transplantation demonstrated that the patient maintained normal blood glucose levels and achieved independence from exogenous insulin. However, by the 12-month mark, a decline in insulin secretion and functional islet performance was noted, which researchers linked to the immunosuppressant switch from tacrolimus to sirolimus. Despite this decline, the patient did not experience any hypoglycemic episodes requiring insulin administration.

Conclusion

The findings suggest that laparoscopic islet transplantation could be a viable method for managing type 1 diabetes mellitus, potentially reducing the need for external insulin. Nonetheless, further research is necessary to assess the long-term safety and effectiveness of this surgical approach.

Written By: Karla Sevilla